Biomarkers and Prognostic Markers in Cardiovascular Diseases
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 20 March 2025 | Viewed by 18
Special Issue Editors
Interests: cardio-thoracic surgery; surgical oncology; bariatric surgery
Special Issues, Collections and Topics in MDPI journals
2. Department of Cardiac Surgery, Lankenau Heart Institute, Main Line Health, Wynnewood, PA 19096, USA
Interests: cardiac surgery; arrhythmias; clinical cardiology; electrophysiology
Special Issue Information
Dear Colleagues,
Cardiovascular disease represents a pandemic that is a leading cause of severe morbidity and mortality for adults worldwide, while reducing patients’ quality of life and imposing a significant financial burden on societies. Although the development of more efficient treatment approaches remains the central goal of modern research, identifying novel biomarkers and prognostic markers to enable earlier diagnosis and more targeted intervention is also critical. In this rapidly changing landscape, we call on all cardiac surgeons, cardiologists, and allied researchers to contribute to this Special Issue and share their own experiences on biomarkers and prognostic markers for cardiovascular disease. Our vision is to provide the best currently available and up-to-date evidence on this important topic, thus providing all the necessary information for a smooth translation of basic research into clinical practice.
Yours faithfully,
Dr. Dimitrios E. Magouliotis
Dr. Serge Sicouri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- cardiovascular disease
- prognostic markers
- prognostic tools
- cardiac disease
- aortic disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
